Alpha Emitter Market

Alpha Emitter Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

196

Base Year:

2023

Feb - 2024

Format:

Report Code:

VMR-2419

Segments Covered

By Radionuclide Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, Others
By Application Prostate Cancer, Bone Metastases, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, Others
By Sources Natural Sources, Artificially produced sources
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 671.2 Million
Revenue 2032:	USD 1751.5 Million
Revenue CAGR (2024 - 2032):	11.25%
Fastest Growing Region (2024 - 2032)	Europe
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Alpha Emitter Market - Segment Analysis
1. Overview
2. Global Alpha Emitter Market, 2016 - 2028 (USD Million)
3. Global Alpha Emitter Market - by Radionuclide
  1. By Radium (Ra-223)
  2. By Actinium (Ac-225)
  3. By Lead (Pb-212)
  4. By Astatine-211
  5. By Bismuth-213
  6. By Others
4. Global Alpha Emitter Market - by Application
  1. By Prostate Cancer
  2. By Bone Metastases
  3. By Ovarian Cancer
  4. By Pancreatic Cancer
  5. By Endocrine Tumors
  6. By Others
5. Global Alpha Emitter Market - by Sources
  1. By Natural Sources
  2. By Artificially produced sources
6. Global Alpha Emitter Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Alpha Emitter Market - Segment Analysis
1. Overview
2. North America Alpha Emitter Market, 2016 - 2028 (USD Million)
3. North America Alpha Emitter Market, by Radionuclide
  1. By Radium (Ra-223)
  2. By Actinium (Ac-225)
  3. By Lead (Pb-212)
  4. By Astatine-211
  5. By Bismuth-213
  6. By Others
4. North America Alpha Emitter Market, by Application
  1. By Prostate Cancer
  2. By Bone Metastases
  3. By Ovarian Cancer
  4. By Pancreatic Cancer
  5. By Endocrine Tumors
  6. By Others
5. North America Alpha Emitter Market, by Sources
  1. By Natural Sources
  2. By Artificially produced sources
6. North America Alpha Emitter Market, by Country
  1. U.S.
    1. U.S. Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. U.S. Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. U.S. Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  2. Canada
    1. Canada Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Canada Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Canada Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  3. Mexico
    1. Mexico Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Mexico Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Mexico Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
Europe Alpha Emitter Market - Segment Analysis
1. Overview
2. Europe Alpha Emitter Market, 2016 - 2028 (USD Million)
3. Europe Alpha Emitter Market, by Radionuclide
  1. By Radium (Ra-223)
  2. By Actinium (Ac-225)
  3. By Lead (Pb-212)
  4. By Astatine-211
  5. By Bismuth-213
  6. By Others
4. Europe Alpha Emitter Market, by Application
  1. By Prostate Cancer
  2. By Bone Metastases
  3. By Ovarian Cancer
  4. By Pancreatic Cancer
  5. By Endocrine Tumors
  6. By Others
5. Europe Alpha Emitter Market, by Sources
  1. By Natural Sources
  2. By Artificially produced sources
6. Europe Alpha Emitter Market, by Country
  1. Germany
    1. Germany Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Germany Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Germany Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  2. UK
    1. UK Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. UK Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. UK Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  3. France
    1. France Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. France Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. France Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  4. Spain
    1. Spain Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Spain Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Spain Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  5. Italy
    1. Italy Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Italy Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Italy Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  6. BENELUX
    1. BENELUX Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. BENELUX Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. BENELUX Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  7. Rest of Europe
    1. Rest Of Europe Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Rest Of Europe Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Rest Of Europe Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
Asia Pacific Alpha Emitter Market - Segment Analysis
1. Overview
2. Asia Pacific Alpha Emitter Market, 2016 - 2028 (USD Million)
3. Asia Pacific Alpha Emitter Market, by Radionuclide
  1. By Radium (Ra-223)
  2. By Actinium (Ac-225)
  3. By Lead (Pb-212)
  4. By Astatine-211
  5. By Bismuth-213
  6. By Others
4. Asia Pacific Alpha Emitter Market, by Application
  1. By Prostate Cancer
  2. By Bone Metastases
  3. By Ovarian Cancer
  4. By Pancreatic Cancer
  5. By Endocrine Tumors
  6. By Others
5. Asia Pacific Alpha Emitter Market, by Sources
  1. By Natural Sources
  2. By Artificially produced sources
6. Asia Pacific Alpha Emitter Market, by Country
  1. China
    1. China Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. China Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. China Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  2. Japan
    1. Japan Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Japan Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Japan Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  3. India
    1. India Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. India Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. India Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  4. South Korea
    1. South Korea Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. South Korea Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. South Korea Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  5. South East Asia
    1. South East Asia Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. South East Asia Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. South East Asia Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Rest of Asia Pacific Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Rest of Asia Pacific Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
Latin America Alpha Emitter Market - Segment Analysis
1. Overview
2. Latin America Alpha Emitter Market, 2016 - 2028 (USD Million)
3. Latin America Alpha Emitter Market, by Radionuclide
  1. By Radium (Ra-223)
  2. By Actinium (Ac-225)
  3. By Lead (Pb-212)
  4. By Astatine-211
  5. By Bismuth-213
  6. By Others
4. Latin America Alpha Emitter Market, by Application
  1. By Prostate Cancer
  2. By Bone Metastases
  3. By Ovarian Cancer
  4. By Pancreatic Cancer
  5. By Endocrine Tumors
  6. By Others
5. Latin America Alpha Emitter Market, by Sources
  1. By Natural Sources
  2. By Artificially produced sources
6. Latin America Alpha Emitter Market, by Country
  1. Brazil
    1. Brazil Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Brazil Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Brazil Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  2. Argentina
    1. Argentina Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Argentina Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Argentina Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  3. Rest of Latin America
    1. Rest of Latin America Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Rest of Latin America Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Rest of Latin America Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
Middle East & Africa Alpha Emitter Market - Segment Analysis
1. Overview
2. Middle East & Africa Alpha Emitter Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Alpha Emitter Market, by Radionuclide
  1. By Radium (Ra-223)
  2. By Actinium (Ac-225)
  3. By Lead (Pb-212)
  4. By Astatine-211
  5. By Bismuth-213
  6. By Others
4. Middle East & Africa Alpha Emitter Market, by Application
  1. By Prostate Cancer
  2. By Bone Metastases
  3. By Ovarian Cancer
  4. By Pancreatic Cancer
  5. By Endocrine Tumors
  6. By Others
5. Middle East & Africa Alpha Emitter Market, by Sources
  1. By Natural Sources
  2. By Artificially produced sources
6. Middle East & Africa Alpha Emitter Market, by Country
  1. GCC Countries
    1. GCC Countries Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. GCC Countries Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. GCC Countries Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  2. South Africa
    1. South Africa Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. South Africa Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. South Africa Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Alpha Emitter Market, By Radionuclide
      1. By Radium (Ra-223)
      2. By Actinium (Ac-225)
      3. By Lead (Pb-212)
      4. By Astatine-211
      5. By Bismuth-213
      6. By Others
    2. Rest of Middle East & Africa Alpha Emitter Market, By Application
      1. By Prostate Cancer
      2. By Bone Metastases
      3. By Ovarian Cancer
      4. By Pancreatic Cancer
      5. By Endocrine Tumors
      6. By Others
    3. Rest of Middle East & Africa Alpha Emitter Market, By Sources
      1. By Natural Sources
      2. By Artificially produced sources
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Actinium Pharmaceutical Inc.
2. Alpha Tau Medical Ltd
3. Bayer AG
4. Bracco
5. Cardinal Health
6. Eckert & Ziegle
7. Fusion Pharmaceuticals
8. IBA Worldwide
9. NorthStar Medical Radioisotopes (NMR)
10. Orano Group
11. Viewpoint Molecular Targeting
12. RadioMedix
13. Telix Pharmaceuticals Limited.
14. TerraPower
15. LLC
16. NIOWAVE Inc. and IONETIX Corporation.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Alpha Emitter in terms of revenue?

The global Alpha Emitter valued at USD 671.2 Million in 2023 and is expected to reach USD 1751.5 Million in 2032 growing at a CAGR of 11.25%.

Which are the prominent players in the market?

The prominent players in the market are Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar Medical Radioisotopes (NMR), Orano Group, Viewpoint Molecular Targeting, RadioMedix, Telix Pharmaceuticals Limited., TerraPower, LLC, NIOWAVE Inc. and IONETIX Corporation..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 11.25% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Alpha Emitter include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Alpha Emitter in 2023.

Alpha Emitter Market

Alpha Emitter Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Alpha Emitter in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Alpha Emitter Market

Alpha Emitter Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Alpha Emitter in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Alpha Emitter Market

Vantage Point Interactive Dashboard